project id: TCGA-SKCM; case submitter id: TCGA-WE-A8ZY; source center: 23; state: released; a260 a280 ratio: 1.87; concentration: 0.17; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.55; rna integrity number: 8.7; age at index: 62; days to birth: -22676; days to death: 1506; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1948; age at diagnosis: 22676; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1330.0; icd 10 code: C44.5; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin of trunk; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1294; days to sample procurement: 0; initial weight: 510.0; portion submitter id: TCGA-WE-A8ZY-06A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;